Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
prostate cancer and hormones
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - International Journal of Radiation Oncology, Biology, Physics
Overall survival rate of patients with T3a and T3b stage prostate... | Download Scientific Diagram
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
Overall survival and prostate cancer specific-survival according to... | Download Scientific Diagram
Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China | Oncotarget
PLOS ONE: Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study - The Lancet Oncology
Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients
A) Progression-free survival and (B) overall survival in... | Download Scientific Diagram
PLOS ONE: Overall survival and second primary malignancies in men with metastatic prostate cancer
Olaparib for Metastatic Castration-Resistant Prostate Cancer | NEJM
Oncotarget: Melatonin increases overall survival of prostate cancer patients | Oncotarget
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer - Clinical Genitourinary Cancer
A) Prostate cancer–specific survival and (B) overall survival... | Download Scientific Diagram
Overall survival of metastatic prostate cancer patients starting... | Download Scientific Diagram
Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database | Scientific Reports
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial - Annals of Oncology
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer - Annals of Oncology
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
